1. Home
  2. TBBK vs ANIP Comparison

TBBK vs ANIP Comparison

Compare TBBK & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Bancorp Inc

TBBK

The Bancorp Inc

N/A

Current Price

$44.47

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$68.65

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TBBK
ANIP
Founded
1999
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
TBBK
ANIP
Price
$44.47
$68.65
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
$63.33
★ $103.38
AVG Volume (30 Days)
★ 528.5K
347.3K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
14.69
★ 419.23
EPS
★ 4.39
3.86
Revenue
$141,147,000.00
★ $206,547,000.00
Revenue This Year
N/A
$24.30
Revenue Next Year
N/A
$10.96
P/E Ratio
★ $10.07
$17.92
Revenue Growth
★ 20.85
2.47
52 Week Low
$43.54
$67.38
52 Week High
$73.02
$87.76

Technical Indicators

Market Signals
Indicator
TBBK
ANIP
Relative Strength Index (RSI) 30.70 41.46
Support Level N/A N/A
Resistance Level $51.18 $74.86
Average True Range (ATR) 1.60 2.49
MACD -0.32 -0.08
Stochastic Oscillator 11.76 14.68

Price Performance

Historical Comparison
TBBK
ANIP

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: